BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 31870440)

  • 21. SP1-induced upregulation of long noncoding RNA LINC00313 contributes to papillary thyroid cancer progression via the miR-422a.
    Yan DG; Liu N; Chao M; Tu YY; Liu WS
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1134-1144. PubMed ID: 30779082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
    Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
    Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
    Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
    J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.
    Wu WJ; Yin H; Hu JJ; Wei XZ
    Neoplasma; 2018 Nov; 65(6):933-942. PubMed ID: 29940766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer.
    Gao Y; Wang F; Zhang L; Kang M; Zhu L; Xu L; Liang W; Zhang W
    Cancer Med; 2020 Feb; 9(4):1515-1528. PubMed ID: 31894666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p.
    Liao G; Huang Z; Gan T; Wu C; Wang X; Li D
    Bioengineered; 2022 May; 13(5):13201-13212. PubMed ID: 35635748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z; Chen R; Huang N; Luo C
    Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
    Zhao Y; Zhao L; Li J; Zhong L
    J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
    Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
    J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
    Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
    Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
    Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis.
    Bai D; Guo C; Wang A; Pang G; Gao J; Wang C; Zhao D; Yang J; Ren J
    Pathol Res Pract; 2021 Sep; 225():153561. PubMed ID: 34325316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
    Jia M; Shi Y; Li Z; Lu X; Wang J
    Cancer Lett; 2019 Feb; 443():145-156. PubMed ID: 30503553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
    Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ
    Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
    Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
    Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
    BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.